Moelis & Company (NYSE: MC), a leading global independent investment
bank, today announced the appointment of Dr. Yvonne Greenstreet as an
independent member of the Board of Directors.
Dr. Greenstreet has over 20 years of experience in the pharmaceutical
industry and has held senior roles in research and development,
strategy, commercial development and portfolio management. She was
formerly Senior Vice President and Head of Medicines Development for
Pfizer where she was a member of the Specialty Business global executive
team. Dr. Greenstreet also spent 18 years at GlaxoSmithKline, most
recently as Senior Vice President and Chief of Strategy for Research and
Development and a member of the corporate portfolio management board.
She held a variety of positions at GlaxoSmithKline prior to this,
including Chief Medical Officer for Europe.
Ken Moelis, Chairman and CEO of Moelis & Company, said, “Yvonne’s wealth
of experience in the pharmaceutical industry and her proven track record
as a highly regarded business leader will greatly benefit our Firm and
our clients. We are delighted to welcome her as Moelis & Company’s
newest Board member.”
Dr. Greenstreet currently serves on the Board of Directors of Pacira
Pharmaceuticals, a specialty pharmaceutical company focused on the
development of products for postsurgical pain control, the Board of
Directors of Advanced Accelerator Applications, a radiopharmaceutical
company that develops diagnostic and therapeutic products, and the Board
of Directors of Indivior, a pharmaceutical company that develops
products to treat addiction. She is also a member of the Scientific
Advisory Board of the Bill & Melinda Gates Foundation.
Dr. Greenstreet holds a Bachelor of Medicine, Bachelor of Surgery from
the University of Leeds, United Kingdom, and an M.B.A. from INSEAD,
France.
About Moelis & Company
Moelis & Company is a leading global independent investment bank that
provides innovative strategic advice and solutions to a diverse client
base, including corporations, governments and financial sponsors. The
Firm assists its clients in achieving their strategic goals by offering
comprehensive integrated financial advisory services across all major
industry sectors. Moelis & Company’s experienced professionals advise
clients on their most critical decisions, including mergers and
acquisitions, recapitalizations and restructurings and other corporate
finance matters. The Firm serves its clients with 550 employees based in
17 offices in North and South America, Europe, the Middle East, Asia and
Australia. For further information, please visit: www.moelis.com.
Copyright Business Wire 2015